| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052733 | The Journal of Urology | 2005 | 8 Pages |
Abstract
Much current research in bladder cancer is aimed at restoring chemosensitivity by shifting the cell toward a pro-apoptotic phenotype. Successful translation of this work into clinical practice may improve survival in patients in whom prognosis is currently poor.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
JOHN JOSEPH MCKNIGHT, SAMUEL B. GRAY, HUGH F. O'KANE, SAMUEL R. JOHNSTON, KATE E. WILLIAMSON,